BioSight
Companies
Pharming Group N.V. logo

PHAR

NASDAQLEIDEN, P7
Pharming Group N.V.

Pharming Group N.V. develops and commercializes biopharmaceutical products, including the marketed drug Joenja (leniolisib) and the product Ruconest. The company operates across multiple therapeutic areas and holds various trademarks and intellectual property related to its pipeline and approved medicines. Based on the filing structure and product portfolio referenced, Pharming appears to be in both commercial and clinical development stages.

Price history not yet available for PHAR.

Pipeline

No pipeline data on record yet.

Catalyst Calendar

No catalyst events on record for yet. Check back after the next daily ingest.

Disclaimer·BioSight aggregates publicly available data (SEC EDGAR, ClinicalTrials.gov, FDA, company press releases) and is provided as is for informational purposes only. Nothing here is investment, financial, legal, tax, or medical advice, or an offer to buy or sell any security. We make no warranty as to accuracy, completeness, or timeliness; dates and filings may contain errors or be superseded without notice; past events do not predict future outcomes. To the maximum extent permitted by law, BioSight, its operators, contributors, and affiliates disclaim all liability for any loss or damage arising from use of or reliance on this site. You are solely responsible for your own investment decisions — consult a licensed professional before acting on any information.

Unlock 12-month calendar